ACTUAL PROBLEMS OF CELL THERAPY FOR CARDIAC DISEASES

Cover Page

Abstract


This article reviews the literatury and own dates of cell therapy for cardiac diseases. The principal unresolved issues were formulated.

 


D. V. Gol'dshtein

Research Center for Medical Genetics RAMS, Moscow
Remetex Close Corporation, Moscow

Author for correspondence.
Email: dv@rm7.ru

Russian Federation доктор биологических наук, профессор, руководитель лаборатории генетики ство- ловых клеток МГНЦ РАМН, генеральный директор ЗАО «РеМеТэкс» Адрес: 115478, Москва, Каширское шоссе, д. 24, стр. 2 Тел.: (495)324-20-24

T. Kh. Fatkhudinov

Institute of Human Morphology RAMS, Moscow
Remetex Close Corporation, Moscow

Email: fatkhudinov@gmail.com

Russian Federation кандидат медицинских наук, в.н.с. лаборатории роста и развития НИИМЧ РАМН, в.н.с. ЗАО «РеМеТэкс» Адрес: 115478, Москва, Каширское шоссе, д. 24, стр. 2 Тел.: (499) 503-96-38

  1. Thomson J., Itskovitz-Eldor J., Shapiro S. et al. Embryonic Stem Cell Lines Derived from Human Blastocysts. Science. 1998; 6 November: 1145–1147.
  2. Kharchenko V. I., Kakorina E. P., Koryakin M. V. i dr. Smertnost’ ot serdechno-sosudistykh zabolevanii v Rossii i v ekonomicheski razvitykh stranakh. Neobkhodimost’ usileniya kardiologicheskoi sluzhby i modernizatsii meditsinskoi statistiki v Rossiiskoi Federatsii (analiticheskii obzor ofitsial’nykh dannykh Goskomstata, Minzdrava Rossii, VOZ i ekspertnykh otsenok po probleme). Rossiiskii kardiologicheskii zhurnal. 2005; № 1 (51): 5–15.
  3. Koroteev A.V., Belyanko I.E.. Khirurgicheskoe lechenie serdechnoi nedostatochnosti. In: Tereshchenko S.N., editor. Nekotorye nereshennye voprosy khronicheskoi serdechnoi nedostatochnosti. Moskva. 2007: 204–223.
  4. Belenkov Yu.N., Oganov R.G.. Kardiologiya. Natsional’noe rukovodstvo. Moskva: Geotar-media. 2007.
  5. Shumakov V.I., Khubutiya M.Sh. Dilatatsionnaya kardiomiopatiya. Moskva. 2003.
  6. Annarosa L. , Kajstura J., Anversa P. Cardiac Stem Cells and Mechanisms of Myocardial Regeneration. Physiol. Rev. 2005; 85: 1373–1416.
  7. Rumyantsev P.P. Kardiomiotsity v protsessakh reproduktsii, differentsirovki i regeneratsii. L.: Nauka. 1982: 288 s.
  8. van Amerongen M.J., Engel F.B. Features of cardiomyocyte proliferation and its potential for cardiac regeneration. J. Cell Mol. Med. 2008 Dec;12(6A):2233–44.
  9. Thiele1 J., Varus E., Wickenhauser C. et al. Regeneration of heart muscle tissue: quantification of chimeric cardiomyocytes and endothelial cells following transplantation. Histol. Histopathol. 2004. 19: 201–209.
  10. ten Hove W.R., Verspaget H.W., Barge R. et al. Liver chimerism after allogeneic blood stem cell transplantation. Transplant. Proc. 2007 Jan-Feb; 39(1):231–236.
  11. Zhang M., Methot D., Poppa V. et al. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J. Mol. Cell. Cardiol. 2001; 33(5):907–921.
  12. Makino S., Fukuda K., Miyoshi S. et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 1999;103(5):697–705.
  13. Passier R., van Laake L., Mummery C. Stem-cell-based therapy and lessons from the heart. Nature. 2008; 453(15): 322–329. 1
  14. Orlic D., Kajstura J., Chimenti S. et al. Bone marrow cells regenerate infarctedmyocardium. Nature. 2001; 410 (5): 701–705.
  15. Dai1 W., Hale S., Kloner R. Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in rats. Regenerative Med. 2007; 2(1): 63–68.
  16. Stamm C., Nasseri B., Choi Y.H. et al. Cell therapy for heart disease: great expectations, as yet unmet. Heart Lung Circ. 2009 Aug;18(4):245–56.
  17. Baikova Yu.P., Fatkhudinov T.Kh., Bol’shakova G.B. i dr. Reparatsiya miokarda pri transplantatsii mononuklearnykh kletok kostnogo mozga. Kletochnye tekhnologii v biologii i meditsine. 2010; 4: 203–211.
  18. Bochkov N.P., Nikitina V.A. Tsitogenetika stvolovykh kletok cheloveka. Molekulyarnaya meditsina. 2008; 3: 40-47.
  19. Wollert K., Drexler H. Cell therapy for the treatment of coronary heart disease: a critical appraisal. Nat. Rev. Cardiol. 2010; 7:204– 215.
  20. Fatkhudinov T.Kh., D’yachkov A.V., Koroteev A.V. i dr. Bezopasnost’ i effektivnost’ transplantatsii allogennykh mul’tipotentnykh stromal’nykh kletok pri khirurgicheskom lechenii dilatatsionnoi kardiomiopatii. Kletochnye tekhnologii v biologii i meditsine. 2010; 1: 10–17.
  21. Kellar R., Landeen L., Shepherd B. et al. Scaffold-Based ThreeDimensional Human Fibroblast Culture Provides a Structural Matrix That Supports Angiogenesis in Infarcted Heart Tissue. Circulation. 2001;104:2063–2068.
  22. Reinecke H., MacDonald G., Hauschka S. et al. Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair. J. Cell Biol. 2000, 149(3):731–740.
  23. Menasche P. Cell-based Therapy for Heart Disease: A Clinically Oriented Perspective. Molecular Therapy. 2009; 17(5): 758–766.
  24. Meyer G., Wollert K., Steffens L. et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months’ followup data from the randomized, controlled BOOST (BOne marrow transfer to enhance ST-elevation infarct regeneration) trial. Circulation. 2002; 113: 1287–1294.
  25. Schachinger V., Assmus B., Honold J. et al. Normalization of coronary blood flow in the infarct-related artery after intracoronary progenitor cell therapy: intracoronary Doppler substudy of the TOPCARE-AMI trial. Clin. Res. Cardiol. 2006 Jan; 95(1): 13–22
  26. Hofmann M., Wollert K., Meyer G. et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation. 2005;111(17):2198–2202.
  27. Patel A., Geffner L., Vina R. Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. J. Thorac. Cardiovasc. Surg. 2005; 130(6): 1631–1638.
  28. Charwat S., Lang I., Dettke M. et al. Effect of intramyocardial delivery of autologous bone marrow mononuclear stem cells on the regional myocardial perfusion. NOGA-guided subanalysis of the MYSTAR prospective randomised study. Thromb Haemost. 2010 Mar;103(3):564–71.
  29. Freyman T., Polin G., Osman H. et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. European Heart Journal. 2006; 27:1114–1122.
  30. Fatkhudinov T.Kh., Slashcheva G.A., Bol’shakova G.B. i dr. Napravleniya migratsii mononuklearov kostnogo mozga pri intrakoronarnom transventrikulyarnom vvedenii. Kletochnye tekhnologii v biologii i meditsine. 2009; 4:222–228.
  31. Bartunek J., Wijns W., Heyndrickx G. et al. Timing of intracoronary bone-marrow-derived stem cell transplantation after ST-elevation myocardial infarction. Nature clinical practice cardiovascular medicine. 2006; 3: 52–56.
  32. Kumar V., Abbas A. et al. 7 ed. Pathologic Basis of Disease. Elsevier Inc. 2004: 1525.
  33. Souders C., Bowers S., Baudino T. Cardiac Fibroblast. The Renaissance Cell. Circ. Res. 2009;105:1164–1176.
  34. Sun Y., Weber K. Infarct scar: a dynamic tissue. Cardiovascular Research. 2000; 46: 250–256.
  35. Jugdutt B. Ventricular Remodeling After Infarction and the Extracellular Collagen Matrix. Circulation. 2003; 108: 1395–1403.
  36. Landa N., Miller L., Feinberg M. Effect of Injectable Alginate Implant on Cardiac Remodeling and Function After Recent and Old Infarcts in Rat. Circulation. 2008; 117: 1388–1396.
  37. Eglitis M., Mezey E. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc. Nat. Acad. Sci. USA. 1997; 94: 4080–4085.
  38. Ferrari G., Cusella-DeAngelis G., Coletta M. et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science. 1998; 279: 1528–1530.
  39. Weissman I., Anderson D., Gage F. Stem and progenitor cells: Origins, phenotypes, lineage commitments, and transdifferentiation. Ann. Rev. Cell. Dev. Biol. 2001;17: 387–403.
  40. Prockop D., Kota D., Bazhanov N. et al. Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs). J. Cell. Mol. Med. 2010; 14(9): 2190–2199.
  41. Lucas J., Terada N. Cell fusion and plasticity. Cytotechnology. 2003; 41: 103–109.
  42. Burchfield J., Dimmeler S. Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis. Fibrogenesis & Tissue Repair. 2008; 1(4): 1–11.
  43. Bochkov N.P. Kletochnaya terapiya v svete dokazatel’noi meditsiny. Klinicheskaya meditsina. 2006;10: 4–9.
  44. Yagudina R.I., Chibilyaev V.A. Ispol’zovanie konechnykh i surrogatnykh tochek v farmakoekonomicheskikh issledovaniyakh. Farmakoekonomika. 2010; 3(2): 12–18.
  45. Suzuki E., Hirata Y., Kohmoto O. et al. Cellular Mechanisms for Synthesis and Secretion of Atrial Natriuretic Peptide and Brain Natriuretic Peptide in Cultured Rat Atrial Cells. Circulation Research. 1992;71: 1039–1048.
  46. Rodriguez-Porcel M. In vivo imaging and monitoring of transplanted stem cells: clinical applications. Curr. Cardiol. Rep. 2010 Jan;12(1):51–8.

Views

Abstract - 30

PDF (Russian) - 3

Cited-By


PlumX



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.